text
"['\nIX. 계열회사 등에 관한 사항\n1. 기업집단의 명칭 : 녹십자 \n2. 기업집단 소속회사의 현황\n구분\n회사수\n회사명\n사업의 내용\n소재지\n사업자등록번호\n상장사\n7\n㈜녹십자홀딩스\n임대, 서비스업\n대한민국\n135-81-05009\n㈜녹십자\n의약품제조및판매\n대한민국\n303-81-17108\n㈜녹십자셀\n의약품제조및판매\n대한민국\n214-86-11207\n㈜녹십자엠에스\n의약품제조및판매\n대한민국\n135-81-67475\n㈜녹십자랩셀\n혈액진단업\n대한민국\n142-81-37741\n㈜녹십자웰빙\n의약품제조\n대한민국\n135-81-72584\n㈜유비케어\n의료정보서비스\n대한민국\n201-81-55688\xa0\n비상장사\n33\n㈜녹십자이엠\n기계설비공사\n대한민국\n135-81-44619\n㈜녹십자헬스케어\n의료서비스\n대한민국\n120-86-55953\n농업회사법인인백팜㈜\n축산업\n대한민국\n408-81-76042\n㈜녹십자지놈\n유전자 분석\n대한민국\n142-81-61687\nCurevo, Inc.\n의약품 연구\n미국\n82-3739400\n㈜지씨웰페어\n기타 서비스업\n대한민국\n142-81-36214\n㈜녹십자메디스\n의료기기\n대한민국\n410-81-93457\n㈜아진디앤엠\n부동산 임대업\n대한민국\n102-87-00194\n㈜지씨씨엘\n임상분석 검체분석\n대한민국\n253-88-01348\n글로벌바이오인프라제이호 사모투자합자회사\n투자조합\n대한민국\n527-87-01408\n㈜에이블애널리틱스\n서비스\n대한민국\n383-81-01126\nGC Lymphotec lnc.\n세포치료제제조및판매\n일본\n0106-01-036063\n녹십자(중국) 생물제품유한공사(GC China)\n의약품제조및판매\n중국\n9134040061037999005\n안휘거린커약품판매유한공사\n의약품 판매\n중국\n913404005957110384(1-1)\nTaoJiang Green Cross PlasmaCenter Co.,Ltd.\n의약품 제조\n중국\n91430922070571693J\nShouXian Green Cross PlasmaCenter Co.,Ltd.\n의약품 제조\n중국\n91340422677573185W\nNingGuo Green Cross PlasmaCenter Co.,Ltd.\n의약품 제조\n중국\n913418817981152286(1-1)\nDangShan Green Cross PlasmaCenter Co.,Ltd.\n의약품 제조\n중국\n913413216789804122(1-1)\nGreen Cross America,Inc.\n의료업\n미국\n80-0510204\nGreen Cross HK Holdings Limited.\n기타 서비스\n홍콩\n52553241-000-07-15-A\nGreen Cross North America Inc.\n기타 서비스\n캐나다\n818724577 RC0001\nGC MOGAM, Inc.\n의약품 판매\n미국\n81-3744746\nGreen Cross BioTherapeutics Inc.\n의약품제조및판매\n캐나다\n827385774 RC0001\nGC Labtech, Inc.\n기타 보건업\n미국\n81-3707136\nGC DO BRASIL PARTICIPACOES LTDA\xa0\n서비스\n브라질\n30.175.318/0001-74\nGC Meizhou Biological Product Co.,Ltd\n의약품 제조\n중국\n91441400MA4W7BMQ46\n㈜브레인헬스케어\n시스템 소프트웨어 개발 및 공급업\n대한민국\n105-88-16294\n㈜브레인씨앤씨\n시스템 소프트웨어 개발 및 공급업\n대한민국\n113-81-90224\n㈜씨알에스큐브세일즈\n응용 소프트웨어 개발 및 공급업\n대한민국\n367-86-01018\n㈜케이컨셉\n의료소프트웨어 개발 및 서비스 공급업\n대한민국\n129-86-58485\n㈜비브로스\n데이터베이스 및 온라인정보 제공업\n대한민국\n114-87-13917\n㈜유팜몰\n인터넷 의약품 판매\n대한민국\n634-88-00456\nNovacel Inc.\n세포치료제 제조\n미국\n84-4228253\n3. 계열회사간 출자 현황\n(기준일 :\xa0\n2020년 09월 30일\n)\n(단위 : %)\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 투자회사피투자회사\n㈜녹십자홀딩스\n㈜녹십자\n㈜녹십자엠에스\n㈜녹십자랩셀\n㈜녹십자이엠\n㈜녹십자셀\n녹십자지놈\n㈜녹십자헬스케어\n㈜유비케어\n㈜브레인헬스케어\n녹십자(중국)생물제품유한공사(GC China)\nGreen Cross HKHoldings Limited.\nGreen CrossNorth America Inc\nGreen Cross BioTherapeutics Inc\n㈜녹십자홀딩스\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n㈜녹십자\n50.06\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n㈜녹십자셀\n4.73\n23.50\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n㈜녹십자엠에스\n\u3000\n41.51\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n㈜녹십자이엠\n100.00\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n㈜녹십자헬스케어\n90.28\n0.18\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n㈜녹십자웰빙\n12.39\n22.08\n0.06\n\u3000\n\u3000\n0.11\n0.11\n\u3000\n\u3000\n\u3000\n\u3000\n농업회사법인 인백팜㈜\n\u3000\n92.55\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n㈜녹십자랩셀\n9.29\n38.66\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n㈜녹십자지놈\n\u300010.36\n33.12\n0.11\n\u3000\n\u3000\n0.14\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n㈜지씨웰페어\n70.00\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n㈜녹십자메디스\n\u3000\n36.85\n61.41\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n㈜지씨씨엘\n\u3000\n\u3000\n\u3000\n67.02\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\nCurevo, Inc.\xa0\n\u3000\n81.36\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n녹십자(중국) 생물제품유한공사(GC China)\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n100.00\n\u3000\n\u3000\n안휘거린커약품판매유한공사\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n100.00\n\u3000\n\u3000\n\u3000\nTaoJiang Green Cross PlasmaCenter Co.,Ltd.\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n100.00\n\u3000\n\u3000\n\u3000\nShouXian Green Cross PlasmaCenter Co.,Ltd.\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n100.00\n\u3000\n\u3000\n\u3000\nNingGuo Green Cross PlasmaCenter Co.,Ltd.\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n100.00\n\u3000\n\u3000\n\u3000\nDangShan Green Cross Plasma Center Co.,Ltd.\n\u3000\n\u3000\n\u3000\n100.00\n\u3000\n\u3000\n\u3000\nGreen Cross America,Inc.\n25.93\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n74.07\nGC MOGAM, Inc.\xa0\n100.00\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\nGreen Cross HK Holdings Limited.\n84.78\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\nGreen Cross North America Inc\n53.15\n46.85\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\nGreen Cross Bio Therapeutics Inc\n\u30006.71\n5.91\n\u3000\n\u3000\n53.40\n\u3000\nGC Labtech, Inc.\n100.00\n\u3000\n\u3000\n\u3000\nGC Meizhou Biological Product Co.,Ltd\n100.00\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\nGC DO BRASIL PARTICIPACOES LTDA\xa0\n\u3000\n99.99\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\nGC Lymphotec lnc.\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n83.27\n\u3000\n\u3000\n글로벌바이오인프라제이호 사모투자합자회사\n49.51\n\u3000\n\u3000\n49.50\n\u3000\n\u3000\n\u3000\n\u3000\n㈜에이블애널리틱스\n100.00\n㈜유비케어\n54.16\n㈜브레인헬스케어\n75.00\n㈜브레인씨앤씨\n100.00\n㈜씨알에스큐브세일즈\n51.00\n㈜케이컨셉\n70.00\n㈜비브로스\n38.49\n㈜유팜몰\n45.00\nNovacel Inc.\n100.00\n※ 상기 지분율은 보통주 기준 지분율 입니다.\n4. 타법인출자 현황\n(기준일 :\xa0\n2020년 09월 30일\n)\n(단위 : 백만원, 주, %)\n법인명\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n㈜녹십자엠에스(상장)\n2010년 11월 25일\n경영참가\n6,837\n8,765,704\n41.5%\n28,383\n-\n-\n-\n8,765,704\n41.5%\n28,383\n85,901\n-16,675\n㈜녹십자셀(상장)\n2012년 08월 16일\n경영참가\n15,000\n2,927,055\n24.2%\n25,024\n-\n-\n-\n2,927,055\n23.5%\n25,024\n151,787\n10,728\n㈜녹십자랩셀(상장)\n2011년 06월 22일\n경영참가\n100\n4,080,000\n38.7%\n2,040\n-\n-\n-\n4,080,000\n38.7%\n2,040\n64,917\n1,691\n농업회사법인 인백팜㈜(비상장)\n2013년 12월 31일\n경영참가\n7,115\n993,690\n92.5%\n7,115\n-\n-\n-\n993,690\n92.5%\n7,115\n18,606\n685\n㈜녹십자웰빙(상장)\n2009년 04월 24일\n경영참가\n9,792\n3,920,250\n22.1%\n11,150\n-\n-\n-\n3,920,250\n22.1%\n11,150\n106,716\n5,699\n㈜녹십자지놈(비상장)\n2013년 08월 01일\n경영참가\n2,031\n4,656,500\n33.3%\n2,328\n-20,000\n-10\n-\n4,636,500\n33.1%\n2,318\n14,010\n233\nGCAM(비상장)(*1)\n2009년 12월 17일\n경영참가\n1,785\n600,000\n25.9%\n6,714\n-\n-\n-\n600,000\n25.9%\n6,714\n53,220\n-8,022\nGCNA(비상장)(*2)\n2014년 04월 22일\n경영참가\n474\n51,544,201\n46.8%\n50,566\n-\n-\n-\n51,544,201\n46.8%\n50,566\n110,838\n-\n㈜녹십자메디스(비상장)\n2015년 01월 27일\n경영참가\n3,873\n11,559,554\n36.8%\n1,360\n-\n-\n-\n11,559,554\n36.8%\n1,360\n6,108\n-325\n한일홀딩스㈜(상장)\n2004년 05월 15일\n단순투자\n5,620\n45,065\n0.8%\n1,978\n-\n-\n12\n45,065\n0.8%\n1,990\n1,286,350\n-61,476\n한일시멘트㈜(상장)\n2004년 05월 15일\n단순투자\n-\n54,934\n1.3%\n5,131\n-\n-\n-626\n54,934\n0.8%\n4,505\n1,383,564\n40,505\nMacroGenics(상장)\n2011년 01월 19일\n단순투자\n2,268\n145,990\n0.3%\n1,839\n-\n-\n2,476\n145,990\n0.3%\n4,315\n397,373\n-139,518\n㈜파멥신(상장)(*3)\n2009년 08월 26일\n단순투자\n104\n281,244\n4.1%\n10,870\n281,244\n-\n1,027\n562,488\n4.0%\n11,897\n161,818\n-9,690\n유바이오로직스(상장)\n2013년 05월 29일\n단순투자\n1,200\n1,640,000\n5.9%\n12,956\n-1,456,000\n-11,502\n2,364\n184,000\n0.6%\n3,818\n92,765\n-882\n㈜연합뉴스티브이(비상장)\n2011년 02월 10일\n단순투자\n500\n100,000\n0.8%\n162\n-\n-\n-\n100,000\n0.8%\n162\n46,657\n5,486\n㈜조선방송(비상장)\n2011년 01월 28일\n단순투자\n2,000\n400,000\n0.7%\n1,605\n-\n-\n-\n400,000\n0.7%\n1,605\n270,716\n3,276\n㈜채널에이(비상장)\n2011년 02월 18일\n단순투자\n2,000\n400,000\n0.5%\n1,282\n-\n-\n-\n400,000\n0.5%\n1,282\n294,052\n-7,528\n㈜매일방송(비상장)\n2011년 03월 04일\n단순투자\n2,000\n266,667\n0.5%\n1,337\n-\n-\n-\n266,667\n0.5%\n1,337\n435,586\n-781\nCurevo, Inc.(비상장)\n2018년 02월 26일\n경영참가\n5,537\n5,000,000\n81.4%\n5,357\n-\n-\n-\n5,000,000\n81.4%\n5,357\n5,670\n-4,525\nCurevo, Inc.(비상장)(*4)\n2019년 07월 30일\n경영참가\n5,880\n-\n-\n5,789\n-\n5,950\n-4\n-\n-\n11,735\n5,670\n-4,525\nGC DO BRASIL (비상장)\n2018년 05월 04일\n경영참가\n534\n1,000,000\n99.9%\n1,125\n-\n-\n-\n1,000,000\n99.9%\n1,125\n817\n-128\n다이노나(상장)\n2000년 08월 25일\n단순투자\n500\n83,330\n0.5%\n433\n-\n-\n34\n83,330\n0.3%\n467\n25,872\n-7,556\n노바자임(비상장)\n2019년 11월 29일\n단순투자\n2,005\n344\n2.7%\n2,005\n-\n-\n-\n344\n2.7%\n2,005\n1,696\n-589\nGreen Cross BioTherapeutics Inc.(비상장)(*1)\r\n2020년 06월 12일\n경영참가\n26,865\n-\n-\n-\n12,179,854\n26,865\n-\n12,179,854\n5.9%\n26,865\n271,978\n-29,930\nGC MOGAM(비상장)\n2020년 08월 27일\n경영참가\n2,220\n-\n-\n-\n5,000,000\n2,220\n-\n5,000,000\n100.0%\n2,220\n374\n-1,737\n㈜카나프테라퓨틱스(비상장)\n2020년 09월 04일\n단순투자\n5,000\n-\n-\n-\n25,380\n5,000\n-\n25,380\n4.0%\n5,000\n6,724\n-2,349\n합 계\n-\n-\n186,549\n-\n28,523\n5,283\n-\n-\n220,355\n-\n-\n(*) 출자비율이 5%를 초과하거나 장부가액이 1억원을 초과하는 타법인 출자현황을기재하였습니다. 또한, 최근사업연도 자료의 확보가 곤란한 비상장사(계열사 제외)는 확보할 수 있는 가장 최근의 재무현황을 기재하였습니다.(*1) 2020년 10월 1일자로 스페인 혈액제제 회사인 Grifols에 처분하였음.(*2) 2020년 10월 22일자로 투자금 회수를 위한 유상감자 실시함.(*3) 무상증자(1:1)로 인해 주식 수 증가함.(2020년 7월 20일 신주 상장)(*4) Curevo 전환사채 투자 건 입니다.\n']"
